Avoro Capital Advisors LLC Dice Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $45.3 Million - $81.8 Million	-1,750,658 Reduced 44.32%	2,199,342 $102 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $37.1 Million - $46 Million	1,424,445 Added 56.4%	3,950,000 $113 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $28.7 Million - $61.3 Million	1,450,555 Added 134.94%	2,525,555 $78.8 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $7.45 Million - $12.8 Million	512,500 Added 91.11%	1,075,000 $20.6 Million
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $5.32 Million - $8.92 Million	-237,500 Reduced 29.69%	562,500 $14.2 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $25.5 Million - $29.6 Million	800,000 New	800,000 $26.2 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.